| 17th Apr 2018 7:00 am |
RNS |
Posting of UK Annual Report and Notice of AGM |
| 11th Apr 2018 2:30 pm |
RNS |
Iclaprim Abstracts for ECCMID 2018 Now Online |
| 10th Apr 2018 7:00 am |
RNS |
Fiscal Year 2017 Results |
| 3rd Apr 2018 3:29 pm |
RNS |
Holding(s) in Company |
| 3rd Apr 2018 7:00 am |
RNS |
Initiation of NDA Rolling Submission for Iclaprim |
| 20th Mar 2018 7:00 am |
RNS |
Motif Bio Update on NDA Submission for Iclaprim |
| 19th Mar 2018 7:00 am |
RNS |
Motif Bio to present at upcoming conferences |
| 13th Mar 2018 3:55 pm |
RNS |
Change of Registered Office |
| 7th Mar 2018 12:29 pm |
RNS |
Exercise of Warrants |
| 1st Mar 2018 7:00 am |
RNS |
Grant of share options to senior management |
| 21st Feb 2018 7:00 am |
RNS |
Motif Bio to Present Iclaprim Data at ECCMID 2018 |
| 19th Feb 2018 12:53 pm |
RNS |
Exercise of Warrants |
| 2nd Feb 2018 3:00 pm |
RNS |
Appointment of Interim Chief Financial Officer |
| 29th Jan 2018 12:07 pm |
RNS |
Second Price Monitoring Extn |
| 29th Jan 2018 12:02 pm |
RNS |
Price Monitoring Extension |
| 19th Jan 2018 7:00 am |
RNS |
Filing of U.S. Shelf Registration |
| 16th Jan 2018 7:00 am |
RNS |
Motif Bio Receives Award from CF Foundation |
| 12th Jan 2018 3:12 pm |
RNS |
Holding(s) in Company |
| 11th Jan 2018 3:07 pm |
RNS |
Holding(s) in Company |
| 8th Jan 2018 3:23 pm |
RNS |
Exercise of Warrants |
| 5th Jan 2018 7:00 am |
RNS |
Motif Bio to participate in panel discussion |
| 22nd Dec 2017 7:01 am |
RNS |
Notes statement from Amphion Innovations |
| 21st Dec 2017 1:00 pm |
RNS |
REVIVE-1 additional results published |
| 14th Dec 2017 7:00 am |
RNS |
Filing of SEC Form F-3 |
| 28th Nov 2017 6:24 pm |
RNS |
Holding(s) in Company |
| 17th Nov 2017 7:00 am |
RNS |
Holding(s) in Company |
| 17th Nov 2017 7:00 am |
RNS |
Exercise of Warrants |
| 15th Nov 2017 7:00 am |
RNS |
Secures up to US$20 million debt financing |
| 9th Nov 2017 2:40 pm |
RNS |
Exercise of Warrants |
| 6th Nov 2017 12:29 pm |
RNS |
Holding(s) in Company |
| 18th Oct 2017 7:00 am |
RNS |
Holding(s) in Company |
| 6th Oct 2017 1:20 pm |
RNS |
Holding(s) in Company |
| 6th Oct 2017 7:00 am |
RNS |
New Pre-Clinical Data for Iclaprim at IDWeek 2017 |
| 5th Oct 2017 9:57 am |
RNS |
Holding(s) in Company |
| 4th Oct 2017 7:00 am |
RNS |
Positive Topline Results in Phase Three Study |
| 29th Sep 2017 7:00 am |
RNS |
Half-year Report |
| 25th Sep 2017 7:01 am |
RNS |
Holding(s) in Company |
| 15th Sep 2017 2:07 pm |
RNS |
iclaprim granted Orphan Drug Designation by US FDA |
| 8th Sep 2017 1:00 pm |
RNS |
Host Investor and Analyst Event on September 20 |
| 31st Aug 2017 1:00 pm |
RNS |
Company to present at conferences in September |
